India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026

India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based g ...
The Pharma Letter

Teva gains biosimilars momentum with FDA approvals

Israel-based Teva Pharmaceutical Industries today announced three milestones in its biosimilar portfolio, demonstrating ...
Pharmabiz

HRV Global Life Sciences and Shodhana Laboratories ink strategic CDMO pact to fast-track high-science & next-generation API development

HRV Global Life Sciences and Shodhana Laboratories ink strategic CDMO pact to fast-track high-science & next-generation API development: Our Bureau, Bengaluru Monday, March 30, 20 ...

Pipeline gaps create M&A opportunities for deal-ready life sciences companies

Joseph Kadlec and Douglas Gray of Troutman Pepper Locke LLP discuss how life sciences companies can position themselves for M&A acquisition amid Big Pharma's search for new pipeline assets.
The Pharma Letter

Pricing, politics and patients: the new drug affordability battle

The USA remains the outlier among wealthy drug markets. OECD data for 2023 put US retail pharmaceutical spending at $1,713 per person, against an OECD average of $766. Germany was at $1,158 and ...
STAT

Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to organization

The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of ...

Pig semen molecule could deliver chemotherapy to hard-to-reach eye cancer, mouse study suggests

Researchers showed that "exosomes" from pig semen may be used in a potential new treatment for retinoblastoma.
Jacaranda FM

Bid for generic Lenacapavir could ‘benefit millions’ – SANAC

The council has opened applications until 7 April for local companies to produce a generic version of the Lenacapavir injection. While the move is aimed at improving access locally, the council says ...
Fieldfisher

ECJ's landmark ruling on defective products liability: What it means for life sciences manufacturers

For the first time, the ECJ has confirmed that victims of defective medicinal products can bring claims not only under the established EU Product Liability Directive (PLD) regime, but also on the ...
Pharmabiz

IPA Kerala joins nationwide protest against DTAB recommendation on competent persons

IPA Kerala joins nationwide protest against DTAB recommendation on competent persons: Peethaambaran Kunnathoor, Chennai Tuesday, March 31, 2026, 08:00 Hrs [IST] The Kerala State B ...
East Coast Radio

Bid for generic Lenacapavir could ‘benefit millions’ – National Aids Council

South Africa plans local production of Lenacapavir, a twice-yearly HIV prevention injection that could protect millions across Africa.
Fierce Pharma

BMS, Novartis, Gilead, Iovance dinged over biologics promos in rare spate of CBER untitled letters

Promotional materials for a handful of biologics have found their way into the FDA’s hot seat. | Promotional materials for a handful of biologics have found their way into the FDA’s hot seat.